Michel Farnier: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemia

Dr Michel Farnier

Journal:

American Journal of Cardiovascular Drugs

Year:

2011

Language:

english

File:

PDF, 233 KB

english, 2011

2

Nouvelles recommandations sur la prise en charge des dyslipidémies

Farnier, Michel

Journal:

La Presse Médicale

Year:

2018

File:

PDF, 752 KB

2018

3

Myalgies et statines : démêler le vrai du faux

Blacher, Jacques, Bruckert, Eric, Farnier, Michel, Ferrières, Jean, Henry, Patrick, Krempf, Michel, Mourad, Jean-Jacques

Journal:

La Presse Médicale

Year:

2019

File:

PDF, 436 KB

2019

4

Long-Term Efficacy and Safety of Rosuvastatin 40 mg in Patients With Severe Hypercholesterolemia

Evan A. Stein, John Amerena, Christie M. Ballantyne, Edmund Brice, Michel Farnier, Robert M. Guthrie, Dror Harats, Patrick T.S. Ma, Florence Le Maulf, Helena Melezínková, Alex Gold, Philip Sager

Journal:

The American Journal of Cardiology

Year:

2007

Language:

english

File:

PDF, 341 KB

english, 2007

5

Quel bilan lipidique et comment l’interpréter chez le patient ayant une maladie coronaire ?

Journal:

La Presse Médicale

Year:

2009

Language:

french

File:

PDF, 331 KB

french, 2009

6

EFFICACY AND SAFETY OF FENOFIBRATE 160 MG IN COMBINATION WITH PRAVASTATIN 40 MG IN TYPE 2 DIABETIC PATIENTS WITH COMBINED HYPERLIPIDEMIA AND WITHOUT CARDIOVASCULAR DISEASE

Michel Farnier, Armin Steinmetz, Kjetil Retterstol, Miroslaw Dluzniewski, Albert Csazar

Journal:

Journal of the American College of Cardiology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

7

Comparison of short-term renal effects and efficacy of rosuvastatin 40 mg and simvastatin 80 mg, followed by assessment of long-term renal effects of rosuvastatin 40 mg, in patients with dyslipidemia

Evan A. Stein, A. David Marais, Jean Ducobu, Michel Farnier, Dov Gavish, Hans Hauner, Andrew J. Kaplan, Florence Le Maulf, Helena Melezínková

Journal:

Journal of Clinical Lipidology

Year:

2007

Language:

english

File:

PDF, 458 KB

english, 2007

8

Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia

Stefano Bertolini, Gabriele Bittolo Bon, L.Malcolm Campbell, Michel Farnier, John Langan, Gerhard Mahla, Paolo Pauciullo, Cesare Sirtori, Fabrice Egros, Rana Fayyad, James W Nawrocki

Journal:

Atherosclerosis

Year:

1997

Language:

english

File:

PDF, 307 KB

english, 1997

9

Rosuvastatin produces significantly greater reductions in low-density lipoprotein cholesterol and more patients achieve treatment goals compared with simvastatin

Ian Hamilton-Craig, Ernst Schaefer, Michel Farnier, Michael Koren, Harry Southworth, John Pears

Journal:

Heart Lung & Circulation

Year:

2003

Language:

english

File:

PDF, 543 KB

english, 2003

10

Safety review of combination drugs for hyperlipidemia

Farnier, Michel

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 237 KB

english, 2011

11

Future Lipid-Altering Therapeutic Options Targeting Residual Cardiovascular Risk

Farnier, Michel

Journal:

Current Cardiology Reports

Year:

2016

Language:

english

File:

PDF, 970 KB

english, 2016

12

Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?

Ghaleb, Youmna, Elbitar, Sandy, El Khoury, Petra, Bruckert, Eric, Carreau, Valérie, Carrié, Alain, Moulin, Philippe, Di-Filippo, Mathilde, Charriere, Sybil, Iliozer, Harout, Farnier, Michel, Luc, Géra

Journal:

European Journal of Human Genetics

Year:

2018

Language:

english

File:

PDF, 709 KB

english, 2018

13

Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

Banach, Maciej, Rizzo, Manfredi, Toth, Peter P., Farnier, Michel, Davidson, Michael H., Al-Rasadi, Khalid, Aronow, Wilbert S., Athyros, Vasilis, Djuric, Dragan M., Ezhov, Marat V., Greenfield, Robert

Journal:

Archives of Medical Science

Year:

2015

Language:

english

File:

PDF, 166 KB

english, 2015

14

Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies

Raal, Frederick J., Tuomilehto, Jaakko, Sposito, Andrei C., Fonseca, Francisco A., Averna, Maurizio, Farnier, Michel, Santos, Raul D., Ferdinand, Keith C., Wright, R. Scott, Navarese, Eliano Pio, Lerc

Journal:

Journal of Clinical Lipidology

Year:

2019

Language:

english

File:

PDF, 1.13 MB

english, 2019

15

Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies

Raal, Frederick J., Tuomilehto, Jaakko, Sposito, Andrei C., Fonseca, Francisco A., Averna, Maurizio, Farnier, Michel, Santos, Raul D., Ferdinand, Keith C., Wright, R. Scott, Navarese, Eliano Pio, Lerc

Journal:

Journal of Clinical Lipidology

Year:

2019

File:

PDF, 1.13 MB

2019

16

The burden of cholesterol accumulation through the lifespan: why pharmacological intervention should start earlier to go further?

Zambon, Alberto, Mello e Silva, Alberto, Farnier, Michel

Journal:

European Heart Journal - Cardiovascular Pharmacotherapy

Year:

2020

File:

PDF, 1.15 MB

2020

17

Reactivity of iminophosphoranes towards some symmetrical dicarbonyl dichlorides : syntheses and mechanisms

Thierry Aubert, Michel Farnier, Roger Guilard

Journal:

Year:

1991

Language:

english

File:

PDF, 450 KB

english, 1991

18

Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease

Helena Vaverkova, Michel Farnier, Maurizio Averna, Luc Missault, Margus Viigimaa, Qian Dong, Arvind Shah, Amy O. Johnson-Levonas, Philippe Brudi

Journal:

Clinical Biochemistry

Year:

2011

Language:

english

File:

PDF, 535 KB

english, 2011

19

A general method for the synthesis of 2-arylpyrroles

Jean Paul Boukou-Poba, Michel Farnier, Roger Guilard

Journal:

Tetrahedron Letters

Year:

1979

Language:

english

File:

PDF, 202 KB

english, 1979

20

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin

Michel Farnier, Qian Dong, Arvind Shah, Amy O Johnson-Levonas, Philippe Brudi

Journal:

Lipids in Health and Disease

Year:

2011

Language:

english

File:

PDF, 175 KB

english, 2011

21

Diabetes: Statins, fibrates, or both?

Michel Farnier, Sylvie Picard

Journal:

Current Atherosclerosis Reports

Year:

2001

Language:

english

File:

PDF, 447 KB

english, 2001

22

Efficacy of Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High-Risk Patients With or Without Obesity

Luc Missault, Maurizio Averna, Michel Farnier, Helena Vaverkova, Margus Viigimaa, Qian Dong, Arvind Shah, Amy O. Johnson-Levonas, William F. Taggart, Philippe Brudi

Journal:

Combination Products in Therapy

Year:

2011

Language:

english

File:

PDF, 677 KB

english, 2011

23

Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin

Journal:

Fundamental & Clinical Pharmacology

Year:

2007

Language:

english

File:

PDF, 41 KB

english, 2007

24

Synthèse d'azido dithiényl-1,2 éthènes et éthanes

Michel Farnier, Michèle Brost, Bernard Hanquet, Roger Guilard

Journal:

Journal of Heterocyclic Chemistry

Year:

1986

File:

PDF, 412 KB

1986

25

Etude de la décomposition thermique d'azido dithiényl-1,2 éthènes et éthanes

Michel Farnier, Michèle Brost, Bernard Hanquet, Roger Guilard

Journal:

Journal of Heterocyclic Chemistry

Year:

1986

Language:

french

File:

PDF, 323 KB

french, 1986

26

Efficacy and Safety of Adding Fenofibrate 160 mg in High-Risk Patients With Mixed Hyperlipidemia Not Controlled by Pravastatin 40 mg monotherapy

Michel Farnier, Jean Ducobu, Leszek Bryniarski

Journal:

The American Journal of Cardiology

Year:

2010

Language:

english

File:

PDF, 382 KB

english, 2010

27

Fixed-Dose Combination Fenofibrate/Pravastatin 160/40 mg Versus Simvastatin 20 mg Monotherapy in Adults With Type 2 Diabetes and Mixed Hyperlipidemia Uncontrolled With Simvastatin 20 mg: A Double-Blind, Randomized Comparative Study

Michel Farnier, Armin Steinmetz, Kjetil Retterstøl, Albert Császár

Journal:

Clinical Therapeutics

Year:

2011

Language:

english

File:

PDF, 496 KB

english, 2011

28

Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil)

Michel Farnier, Michele Bortolini, Thomas Salko, Marie-Odile Freudenreich, Jonathan L. Isaacsohn, August J. Troendle, Leonard Gonasun

Journal:

The American Journal of Cardiology

Year:

2003

Language:

english

File:

PDF, 61 KB

english, 2003

29

Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil)

Michel Farnier, Thomas Salko, Jonathan L Isaacsohn, August J Troendle, Sylvie Dejager, Leonard Gonasun

Journal:

The American Journal of Cardiology

Year:

2003

Language:

english

File:

PDF, 75 KB

english, 2003

30

Current and future treatment of hyperlipidemia: the role of statins

Michel Farnier, Jean Davignon

Journal:

The American Journal of Cardiology

Year:

1998

Language:

english

File:

PDF, 117 KB

english, 1998

31

Cerivastatin in the treatment of mixed hyperlipidemia: the right study

Journal:

The American Journal of Cardiology

Year:

1998

Language:

english

File:

PDF, 92 KB

english, 1998

32

Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia

Michel Farnier, Sylvie Dejager

Journal:

The American Journal of Cardiology

Year:

2000

Language:

english

File:

PDF, 73 KB

english, 2000

33

Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia

Michel Farnier, Eli Roth, Blas Gil-Extremera, Gustavo F. Mendez, Geraldine Macdonell, Constance Hamlin, Inna Perevozskaya, Michael J. Davies, Debra Kush, Yale B. Mitchel

Journal:

American Heart Journal

Year:

2007

Language:

english

File:

PDF, 176 KB

english, 2007

34

Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease

Michel Farnier, Massimo Volpe, Rachid Massaad, Michael J. Davies, Christopher Allen

Journal:

International Journal of Cardiology

Year:

2005

Language:

english

File:

PDF, 113 KB

english, 2005

35

Hypercholestérolémies, le futur des associations médicamenteuses

James Shepherd, Jean-Pierre Bassand, Hugues Milon, Michel Farnier

Journal:

La Presse Médicale

Year:

2004

Language:

french

File:

PDF, 519 KB

french, 2004

36

Synthesis and characterization of bis(phenyltetrazolato)-germanium(IV) and -tin(IV) porphyrins

Jagerovic, Nadine, Barbe, Jean-Michel, Farnier, Michel, Guilard, Roger

Journal:

Journal of the Chemical Society Dalton Transactions

Year:

1988

Language:

english

File:

PDF, 338 KB

english, 1988

37

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy

Helena Vaverkova, Michel Farnier, Maurizio Averna, Luc Missault, Margus Viigimaa, Qian Dong, Arvind Shah, Amy O. Johnson-Levonas, Philippe Brudi

Journal:

Cardiovascular Therapeutics

Year:

2012

Language:

english

File:

PDF, 895 KB

english, 2012

38

Recherches en série hétérocyclique. XXVII. Etude de la condensation de l'azidoacétate d'éthyle sur les thiophènedicarbaldéhydes-2,5, -2,4 et -3,4

Farnier, Michel, Soth, Samreth, Fournari, Pierre

Journal:

Canadian Journal of Chemistry

Year:

1976

File:

PDF, 473 KB

1976

39

Comparative effects of simvastatin and pravastatin on cholesterol synthesis in patients with primary hypercholesterolemia

Christine Feillet, Michel Farnier, Louis H. Monnier, Christine Percheron, Claude Colette, Bernard Descomps, AndréCrastes De Paulet

Journal:

Atherosclerosis

Year:

1995

Language:

english

File:

PDF, 920 KB

english, 1995

40

Circulating leukocyte telomere length and oxidative stress: A new target for statin therapy

Sebastien Saliques, Jean-Raymond Teyssier, Catherine Vergely, Luc Lorgis, Julie Lorin, Michel Farnier, Anne Donzel, Pierre Sicard, Juliane Berchoud, Anne-Cécile Lagrost, Claude Touzery, Sylviane Ragot

Journal:

Atherosclerosis

Year:

2011

Language:

english

File:

PDF, 255 KB

english, 2011

41

Effects of Ezetimibe, Simvastatin, and Ezetimibe/Simvastatin on Apolipoprotein B, Low-Density Lipoprotein Cholesterol, and Non–High-Density Lipoprotein Cholesterol Targets in Patients with Primary Hypercholesterolemia†

John R. Guyton, Michel Farnier, Erin H. Jensen, Adam B. Polis, Amy O. Johnson-Levonas, Philippe Brudi

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

42

Greater Dissociation of apoB, LDL-C and Non-HDL-C Targets in Patients Treated with Extended-Release Niacin/Laropiprant and Simvastatin Either Alone or in Combination†

Joseph Triscari, Michel Farnier, Erluo Chen, Amy O. Johnson-Levonas, Yale B. Mitchel

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 42 KB

english, 2012

43

Effects of gemfibrozil on serum apolipoprotein E distribution in hypercholesterolemic patients

Philippe Gambert, Michel Farnier, Gilbert Girardot, Jean-Marvel Brun, Christian Lallemant

Journal:

Atherosclerosis

Year:

1991

Language:

english

File:

PDF, 302 KB

english, 1991

44

Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design

Jean-Marc Lablanche, Nicolas Danchin, Michel Farnier, Alain Tedgui, Eric Vicaut, Joaquim Alonso, Peter Crean, Attilio Leone, Joa Morais, Massimo Santini, Muriel Licour, Mohamed Farah, Jean-Claude Tard

Journal:

Archives of Cardiovascular Diseases

Year:

2008

File:

PDF, 464 KB

2008

45

A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE)

Philippe Gabriel Steg, Jean-Claude Verdier, François Carré, Bernadette Darne, Alain Ducardonnet, Gérard Jullien, Michel Farnier, Philippe Giral, Robert Haïat

Journal:

Archives of Cardiovascular Diseases

Year:

2008

File:

PDF, 711 KB

2008

46

Severe familial hypercholesterolaemia: Current and future management

Farnier, Michel, Bruckert, Eric

Journal:

Archives of Cardiovascular Diseases

Year:

2012

File:

PDF, 354 KB

2012

47

Safety and Efficacy of Long-Term Co-Administration of Fenofibrate and Ezetimibe in Patients With Mixed Hyperlipidemia

James M. McKenney, Michel Farnier, Kwok-Wing Lo, Harold E. Bays, Inna Perevozkaya, Gary Carlson, Michael J. Davies, Yale B. Mitchel, Barry Gumbiner

Journal:

Journal of the American College of Cardiology

Year:

2006

Language:

english

File:

PDF, 85 KB

english, 2006

48

High Serum Cholesteryl Ester Transfer Rates and Small High-Density Lipoproteins Are Associated With Young Age in Patients With Acute Myocardial Infarction

Marianne Zeller, David Masson, Michel Farnier, Luc Lorgis, Valérie Deckert, Jean-Paul Pais de Barros, Catherine Desrumaux, Pierre Sicard, Jacques Grober, Denis Blache, Philippe Gambert, Luc Rochette,

Journal:

Journal of the American College of Cardiology

Year:

2007

Language:

english

File:

PDF, 316 KB

english, 2007

49

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20mg Compared with Rosuvastatin 10mg in High-Risk Patients with and Without Type 2 Diabetes Mellitus (T2DM)

Philippe Brudi, Helena Vaverkova, Michel Farnier, Maurizio Averna, Margus Viigimaa, Qian Dong, Arvind Shah, Amy O. Johnson-Levonas, Luc Missault

Journal:

Journal of Clinical Lipidology

Year:

2009

Language:

english

File:

PDF, 96 KB

english, 2009

50

Lower LDL-C values Should Be Reached to Normalize Apolipoprotein B Concentrations in Hypertriglyceridemic Patients Receiving Lipid-lowering Therapy

Philippe D.P. Brudi, John Betteridge, John Guyton, Michel Farnier, Lawrence Leiter, Jianxin Lin, Arvind Shah, Amy Johnson-Levonas

Journal:

Journal of Clinical Lipidology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011